Daisy Woellner-Santos

Daisy Woellner-Santos

Auto-generated profile, based on publicly available information

Daisy Woellner-Santos

Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2024 in npj Vaccines
Verified
Journal Article
Open access
PDF file
DWDaisy Woellner-Santos
Daisy Woellner-Santos
ATAna Tahira
Ana Tahira
JMJoão V. M. Malvezzi
João V. M. Malvezzi
VMVinicius Mesel
Vinicius Mesel
DMDavid A. Morales-Vicente
David A. Morales-Vicente
SVSergio Verjovski-Almeida
Sergio Verjovski-Almeida
Schistosomiasis, a challenging neglected tropical disease, affects millions of people worldwide. Developing a prophylactic vaccine againstSchistosoma mansonihas been hindered by the parasite’s biological complexity. In this study, we utilized the innovative phage-display immunoprecipitation followed by a sequencing approach (PhIP-Seq) to screen the immune response of 10 infected rhesus macaques during self-cure and challenge-resistant phases, identifying vaccine candidates. Our high-throughputS. mansonisynthetic DNA phage-display library encoded 99.6% of 119,747 58-mer peptides, providing comprehensive coverage of the parasite’s proteome. Library screening with rhesus macaques’ antibodies, from the early phase of establishment of parasite infection, identified significantly enriched epitopes of parasite extracellular proteins known to be expressed in the digestive tract, shifting towards intracellular proteins during the late phase of parasite clearance. Immunization of mice with a selected pool of PhIP-Seq-enriched phage-displayed peptides from MEG proteins, cathepsins B, and asparaginyl endopeptidase significantly reduced worm burden in a vaccination assay. These findings enhance our understanding of parasite-host immune responses and provide promising prospects for developing an effective schistosomiasis vaccine.

26 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DMDavid A. Morales-Vicente
David A. Morales-Vicente
ATAna Tahira
Ana Tahira
DWDaisy Woellner-Santos
Daisy Woellner-Santos
MAMurilo Sena Amaral
Murilo Sena Amaral
MBMaria Gabriela Berzoti-Coelho
Maria Gabriela Berzoti-Coelho
SVSergio Verjovski-Almeida
Sergio Verjovski-Almeida
Background: Outstanding human cognitive abilities are computed in the cerebral cortex, a mammalian-specific brain region and the place of massive biological innovation. Long noncoding RNAs (lncRNAs) have emerged as gene regulatory elements with higher evolutionary turnover than mRNAs. The many lncRNAs identified in neural tissues make them candidates for molecular sources of cerebral cortex evolution and disease. Here, we characterized the genomic and cellular shifts that occurred during the evolution of the lncRNA repertoire expressed in the developing cerebral cortex of humans and explored their role in the evolution of this brain region. Results: Using systems biology approaches and comparative transcriptomics, we comprehensively annotated the cortical transcriptomes of humans, macaques, mice, and chickens and classified human cortical lncRNAs into evolutionary groups as a function of their predicted minimal ages. LncRNA evolutionary groups showed differences in expression levels, splicing efficiencies, transposable element contents, genomic distributions, and transcription factor binding to their promoters. Furthermore, older lncRNAs showed preferential expression in germinative zones, outer radial glial cells, and cortical inhibitory neurons. In comparison, younger lncRNAs showed preferential expression in cortical excitatory neurons, belonged to human-specific gene coexpression modules, and were dysregulated in autism spectrum disorder. Conclusions: These results suggest a shift in the roles of cortical lncRNAs over evolution, highlighting the antique lncRNAs as a source of molecular evolution of conserved developmental programs; conversely, the de novo expression of primate and human-specific lncRNAs are sources of molecular evolution and dysfunction of cortical excitatory neurons.

21 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DWDaisy Woellner-Santos
Daisy Woellner-Santos
KZKamryn Zadeii
Kamryn Zadeii
RDRian DelVecchio
Rian DelVecchio
MSMia Somenzi
Mia Somenzi
ALAmérico López-Yglesias
Américo López-Yglesias
The transcription factor T-bet is widely regarded as the master regulator of type 1 immunity and is considered essential for host resistance to intracellular pathogens. Previous studies have demonstrated that global T-bet deficiency causes profound susceptibility to intracellular pathogens, including T . gondii . However, the specific cell-intrinsic requirement for T-bet within CD4⁺ T cells has remained unclear because T-bet regulates multiple innate and adaptive immune populations that contribute to protective immunity. Therefore, to define the cell-intrinsic role of T-bet in CD4⁺ T cells during infection, we utilized mice with conditional T-bet deletion in CD4⁺ T cells (CD4- Tbx21 −/− ) and found that CD4⁺ T cell-intrinsic T-bet was largely dispensable for acute parasite control and the generation of antigen-experienced IFN-γ-producing CD4⁺ T cells. However, although CD4- Tbx21 −/− mice controlled acute infection, our data reveal that as infection transitions to the chronic stage, CD4⁺ T cell-intrinsic T-bet becomes critical for sustaining cerebral immunity, promoting IFN-γ-dependent antimicrobial responses, and maintaining parasite control within the brain. Collectively, our findings establish that CD4⁺ T cell-intrinsic T-bet is required for sustaining protective CD4⁺ T cell responses within the infected CNS and promotes IFN-γ-dependent antiparasitic mechanisms that restrict tachyzoite persistence during the transition to chronic infection. Author Summary: Toxoplasma gondii is an intracellular parasite that can establish lifelong infection in the brain, where continuous immune responses are required to prevent parasite reactivation and disease. CD4⁺ T cells are central to this protection, and their effector functions are commonly associated with the transcription factor T-bet, a key regulator of type 1 immunity. Our previous work demonstrated that T-bet-dependent IFN-γ from innate lymphoid cells is essential for maintaining inflammatory dendritic cells during infection, yet CD4⁺ T cells can still produce IFN-γ even without T-bet. This raised the question of whether T-bet is truly required within CD4⁺ T cells to control T. gondii . To address this, we used mice lacking T-bet specifically in CD4⁺ T cells. Notably, these mice controlled early infection and generated IFN-γ-producing CD4⁺ T cells, demonstrating that T-bet is not strictly required to initiate these protective responses. However, as infection progressed, the absence of T-bet compromised the long-term maintenance of protective CD4⁺ T cell responses in the brain, resulting in impaired antimicrobial defenses and increased parasite persistence. Our findings reveal that the importance of T-bet in CD4⁺ T cells changes over the course of infection, becoming particularly critical for sustaining protective immunity in the central nervous system. These results provide new insight into how CD4⁺ T cells maintain control of persistent intracellular pathogens.

25 July 2026 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
MSMia C. Somenzi
Mia C. Somenzi
KBKameron T. Bell
Kameron T. Bell
ABAbigail M. Bitters
Abigail M. Bitters
CSCollin S. Stratton
Collin S. Stratton
SSSamantha R. Springston
Samantha R. Springston
ALAmérico H. López-Yglesias
Américo H. López-Yglesias
The obligate intracellular parasite Toxoplasma gondii infects nearly one-third of the global population, yet its impact on human blood–brain barrier